Skip to content

Tango Therapeutics

US · TNGX #2322 by market cap Listed 1970
21.73 -0.98 -4.32%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:41

Quant vs Street three independent views, side by side

StockVane factor grade
B+
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Jefferies moved from Hold to Buy on 2026-06-25.

Analyst consensus 6 analysts

Buy
Avg price target 48.67 +124.0%
Price target rangecurrent 21.73
Low35.00
Avg48.67
High67.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-10 CCORF -- Buy 46.00
2026-11-10 H.C. Wainwright -- Buy 67.00
2026-11-10 J.P. Morgan -- Buy 47.00
2026-11-09 Guggenheim -- Buy 35.00
2026-11-09 J.P. Morgan -- Buy 47.00
2026-10-29 H.C. Wainwright -- Buy 68.00
2026-10-23 CCORF -- Buy 46.00
2026-10-23 Stifel -- Buy 55.00
2026-10-23 J.P. Morgan -- Buy --
2026-10-15 William Blair -- Buy 42.00
2026-10-13 J.P. Morgan -- Buy --
2026-10-12 CCORF -- Buy 46.00
2026-10-08 CCORF -- Buy 46.00
2026-09-24 CCORF -- Buy 46.00
2026-09-24 Guggenheim -- Buy 35.00
2026-09-11 CCORF -- Buy 46.00
2026-08-18 H.C. Wainwright -- Buy 68.00
2026-08-17 Stifel -- Buy 40.00
2026-08-12 CCORF -- Buy 46.00
2026-08-12 Wedbush -- Buy 39.00
2026-08-11 CCORF -- Buy 46.00
2026-08-11 Guggenheim -- Buy 35.00
2026-08-06 CCORF -- Buy 46.00
2026-07-30 CCORF -- Buy 46.00
2026-07-23 CCORF -- Buy 46.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-06-25 Jefferies Hold → Buy 60.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2025/Q4 2026-03-05 -- -- +36.28%
2025/Q3 2025-11-04 -- ±18.41% +0.00% (in line)
2025/Q2 2025-08-05 -- ±42.88% +4.86% (in line)
2025/Q1 2025-05-12 -- -- +14.91%

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:41:45 · For reference only, not investment advice and not tailored to your situation.

Tango Therapeutics discussion 0 comments

Add a comment